Figure 2.
Description of IPP 9-mRNA and clinical parameters in the RICO cohort of 309 critically ill COVID-19 patients. (A) Expression of IPP markers (values are presented as normalized Cp). (B) Age (years). (C) Clinical scores. All parameters are presented at admission between 28-day survivors (green) and non-survivors (red). When relevant, reference values of healthy donors are presented in grey. The p-value were generated using a Mann-Whitney-Wilcoxon test between survivors and non-survivors.